Mycobacterium tuberculosis cell wall biosynthesis component

The Mycobacterium tuberculosis cell wall biosynthesis component encompasses the enzymes and structural proteins involved in the assembly of the unique, multi-layered mycobacterial cell envelope (Brennan, 2003). This structure is characterized by a core of peptidoglycan linked to arabinogalactan, which is further modified by long-chain mycolic acids to form a highly impermeable barrier (Alderwick et al., 2015). This cell wall is essential for the bacterium's survival, virulence, and resistance to host immune defenses and many conventional antibiotics (Marrakchi et al., 2014). Therapeutic agents like isoniazid and ethambutol target specific enzymes within these pathways, such as InhA and EmbB, respectively, to disrupt cell wall integrity and induce bacterial death (Vilchèze & Jacobs, 2007). Because these specific biosynthetic pathways are absent in humans, these components are high-priority targets for the development of narrow-spectrum antibacterial drugs (Kaur et al., 2009). Disruption of these components often leads to rapid bactericidal effects, making them cornerstones of modern tuberculosis treatment regimens. Ongoing research continues to identify novel enzymes within this machinery to combat the rising threat of multi-drug resistant tuberculosis strains.

Other names

Mycobacterial cell wall synthesis machineryMtb cell wall enzymesCell wall biosynthetic pathwayMycobacterium tuberculosis cell wall

Inhibition of the synthesis of essential cell wall components such as mycolic acids, arabinogalactan, or peptidoglycan (Vilchèze & Jacobs, 2007).